How big is the Global Narcolepsy Therapeutics Market?

The Global Narcolepsy Therapeutics Market size is expected to reach USD 3.80 billion in 2024 and grow at a CAGR of 8.04% to reach USD 5.60 billion by 2029. Read More

What is the current Global Narcolepsy Therapeutics Market size?

In 2024, the Global Narcolepsy Therapeutics Market size is expected to reach USD 3.80 billion. Read More

Who are the key players in Global Narcolepsy Therapeutics Market?

Jazz Pharmaceuticals plc, Harmony Biosciences, Teva Pharmaceuticals Industries Ltd, Azurity Pharmaceuticals, Inc. and Avadel Pharmaceuticals are the major companies operating in the Global Narcolepsy Therapeutics Market. Read More

Which is the fastest growing region in Global Narcolepsy Therapeutics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Narcolepsy Therapeutics Market?

In 2024, the North America accounts for the largest market share in Global Narcolepsy Therapeutics Market. Read More

What years does this Global Narcolepsy Therapeutics Market cover, and what was the market size in 2023?

In 2023, the Global Narcolepsy Therapeutics Market size was estimated at USD 3.49 billion. The report covers the Global Narcolepsy Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Narcolepsy Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Narcolepsy Therapeutics Market Share

Statistics for the 2023 & 2024 Global Narcolepsy Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Global Narcolepsy Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Narcolepsy Therapeutics Industry

The narcolepsy therapeutics market is moderately consolidated. Collaborations and acquisitions to share technology and costs for innovation in the field are expected to be observed. The development of novel therapies and approval by international regulatory agencies drives the market. Some major players include Avadel, Harmony Biosciences (BIOPROJET), Jazz Pharmaceuticals PLC, Azurity Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.